Active Stocks Pre-Market Notes -- Research on Johnson Controls, EXCO Resources, Inovio Pharma, and US Bancorp.

LONDON, April 29, 2014 /PRNewswire/ --

The markets on Monday, April 28, 2014 ended mostly on a higher note as the Dow Jones Industrial Average finished at 16,448.74, up 0.53% and the NASDAQ Composite closed at 4,074.40, down 0.03%. The S&P 500 edged 0.32% higher, to finish the day at 1,869.43. The gains were broad based as seven out of ten sectors finished on a higher note. During the session, gains in the Telecommunication Services, Consumer Staples and Information Technology sectors positively impacted the broader market, while some retraction came in from Financials, Materials and Consumer Discretionary sectors. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Johnson Controls Inc. (NYSE: JCI), EXCO Resources Inc. (NYSE: XCO), Inovio Pharmaceuticals Inc. (NYSE MKT: INO) and US Bancorp. (NYSE: USB). Free technical research on JCI, XCO, INO and USB can be downloaded upon signing up at:

http://www.investor-edge.com/1839-register

Johnson Controls Inc.'s stock finished Monday's session 1.91% lower at $43.64. A total of 7.50 million shares were traded, which was above its three months average volume of 4.11 million shares. The stock moved between $43.16 and $44.90 during the session. Over the previous three trading sessions, and on YTD basis, Johnson Controls Inc.'s shares have declined 6.07% and 14.93%, respectively. The S&P 500 Consumer Discretionary Sector Index edged 0.66% lower in the previous three months, while the NASDAQ Composite Index fallen by 0.57% during the same period.The company's shares are trading below its 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $47.56 is greater than its 200-day moving average of $45.70. Further, Johnson Controls Inc.'s stock traded at a PE ratio of 14.27 and has a Relative Strength Index (RSI) of 38.07. Sign up today to read free research on JCI at:

http://www.investor-edge.com/1839-JCI-29Apr2014.pdf

On Monday, EXCO Resources Inc.'s stock advanced 4.05%, closing the day at $6.16. The stock recorded a trading volume of 7.44 million shares, much above its three months average volume of 5.96 million shares. The stock oscillated between $5.94 and $6.22 during the trading session. EXCO Resources Inc.'s shares have surged 11.80% in the last one month and 12.00% in the previous three months, and the stock has gained 16.01% since the start of this year. The S&P 500 Energy Sector Index gained 9.82% in the previous three months, while the S&P 500 advanced 4.29% during the same period. EXCO Resources Inc.'s stock is trading above its 50-day and 200-day moving averages of $5.45 and $6.10, respectively. Moreover, shares of the company have an RSI of 54.73. Sign up today to read free research on XCO at:

http://www.investor-edge.com/1839-XCO-29Apr2014.pdf

Shares of Inovio Pharmaceuticals Inc. traded between $2.19 and $2.44 before ending the day 3.32% lower at $2.33. The company's stock reported a trading volume of 5.58 million shares on Monday, which was below its three months average volume of 8.05 million shares. Inovio Pharmaceuticals Inc.'s shares have plummeted 10.73% in the previous three trading sessions, 7.91% in the last three months, and 19.66% on YTD basis. The S&P 500 Health Care Sector Index gained 3.15% in the previous three months, while the S&P 500 advanced 4.29% during the same period. The stock is trading below its 50-day and 200-day moving averages. Moreover, Inovio Pharmaceuticals Inc.'s 50-day moving average of $3.20 is greater than its 200-day moving average of $2.36. Additionally, the company's stock has an RSI of 34.47. Sign up today to read free research on INO at:

http://www.investor-edge.com/1839-INO-29Apr2014.pdf

On Monday, US Bancorp.'s stock reported a trading volume of 8.30 million shares, which was above its three months average volume of 7.58 million shares. The stock ended the day at $40.16, which was 0.15% lower to its previous day's closing, and registered an intraday trading range of $39.86 and $40.38. Shares of the company traded at a PE ratio of 13.34. US Bancorp.'s shares have declined 1.91% in the previous three trading sessions, 0.94% in the last three months and 0.59% on YTD basis. The S&P 500 Financials Sector Index gained 2.23% in the previous three months, while the NASDAQ Composite Index fell by 0.57% during the same period. US Bancorp.'s stock is trading above its 200-day moving average of $39.09. Furthermore, shares of the company have an RSI of 37.48. Sign up today to read free research on USB at:

http://www.investor-edge.com/1839-USB-29Apr2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge